Abstract
MA 02.02 Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jtho.2017.09.452
Journal: Journal of Thoracic Oncology | Publication Date: Nov 1, 2017 |
Citations: 1 | License type: publisher-specific-oa |
MA 02.02 Phase 2 Study of Pembrolizumab Plus CC-486 vs Pembrolizumab Plus Placebo in Previously Treated Patients with Advanced NSCLC
Join us for a 30 min session where you can share your feedback and ask us any queries you have